Rev Esp Quimioter 2023; 36(5): 470-476

Adequacy of the consumption of antipseudomonal antibiotics after changes in the 2019 EUCAST criteria

ELENA HERRANZ-BAYO, RAFAEL HUARTE-LACUNZA, ANDREA PINILLA-RELLO, IRENE AGUILÓ-LAFARGA, ANA ISABEL LÓPEZ-CALLEJA

Published: 7 June 2023

http://www.doi.org/10.37201/req/137.2022

Introduction. In 2019, the European Committee for the Study of Antibiotic Susceptibility modified the categories of antibiotic susceptibility tests to include the term “susceptible with increased exposure”. Following the dissemination of local protocols reflecting these modifications, the aim of our study was to analyse whether prescribers have adapted to them and the clinical impact in cases of inadequacy.
Material and methods. Observational and retrospective study of patients with infection who received antipseudomonal antibiotics from January to October 2021 in a tertiary hospital.
Results. Non-adherence to the guideline recommendations was 57.6% in the ward and 40.4% in the ICU (p<0.05). In both the ward and ICU, the group with the most prescriptions not by the guideline recommendations were aminoglycosides (92.9% and 64.9% respectively) for using suboptimal doses, followed by carbapenems (89.1% and 53.7% respectively) for not administering an extended infusion. On the ward, the mortality rate during admission or at 30 days in the inadequate therapy group was 23.3% vs 11.5% in those who received adequate treatment (OR: 2.34; 95% CI 1.14-4.82); in ICU there were no statistically significant differences.
Conclusions. The results show the need to implement measures to ensure better dissemination and knowledge of key concepts in antibiotic management, to ensure increased exposures, and to be able to provide better infection coverage, as well as to avoid amplifying resistant strains.

Rev Esp Quimioter 2023; 36(5): 470-476 [Texto completo PDF] [Material suplementario – PDF]